1. Home
  2. MGRX vs MYNZ Comparison

MGRX vs MYNZ Comparison

Compare MGRX & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGRX
  • MYNZ
  • Stock Information
  • Founded
  • MGRX 2021
  • MYNZ 2021
  • Country
  • MGRX United States
  • MYNZ Germany
  • Employees
  • MGRX N/A
  • MYNZ N/A
  • Industry
  • MGRX Computer Software: Prepackaged Software
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • MGRX Technology
  • MYNZ Health Care
  • Exchange
  • MGRX Nasdaq
  • MYNZ Nasdaq
  • Market Cap
  • MGRX 9.3M
  • MYNZ 9.8M
  • IPO Year
  • MGRX 2023
  • MYNZ 2021
  • Fundamental
  • Price
  • MGRX $0.40
  • MYNZ $0.36
  • Analyst Decision
  • MGRX
  • MYNZ Buy
  • Analyst Count
  • MGRX 0
  • MYNZ 2
  • Target Price
  • MGRX N/A
  • MYNZ $3.00
  • AVG Volume (30 Days)
  • MGRX 1.6M
  • MYNZ 1.4M
  • Earning Date
  • MGRX 07-30-2024
  • MYNZ 08-13-2024
  • Dividend Yield
  • MGRX N/A
  • MYNZ N/A
  • EPS Growth
  • MGRX N/A
  • MYNZ N/A
  • EPS
  • MGRX N/A
  • MYNZ N/A
  • Revenue
  • MGRX $844,866.00
  • MYNZ $895,479.00
  • Revenue This Year
  • MGRX N/A
  • MYNZ $67.40
  • Revenue Next Year
  • MGRX N/A
  • MYNZ $191.13
  • P/E Ratio
  • MGRX N/A
  • MYNZ N/A
  • Revenue Growth
  • MGRX 670.43
  • MYNZ 69.00
  • 52 Week Low
  • MGRX $0.14
  • MYNZ $0.32
  • 52 Week High
  • MGRX $1.59
  • MYNZ $4.71
  • Technical
  • Relative Strength Index (RSI)
  • MGRX 56.43
  • MYNZ 39.72
  • Support Level
  • MGRX $0.35
  • MYNZ $0.34
  • Resistance Level
  • MGRX $0.47
  • MYNZ $0.46
  • Average True Range (ATR)
  • MGRX 0.05
  • MYNZ 0.07
  • MACD
  • MGRX 0.01
  • MYNZ 0.00
  • Stochastic Oscillator
  • MGRX 60.00
  • MYNZ 9.09

About MGRX Mangoceuticals Inc.

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

Share on Social Networks: